HAL's Principal Activity is the equities research and trade execution platform.
|Bid / Ask||-|
|Volume (4w avg)|
|vs Sector (1yr)||-|
|vs ASX 200 (1yr)||-48.46%|
Halo Technologies Holdings Limited (HAL) is an online global equities research and trade execution software solution that brings institutional-grade analytical frameworks and market insights to investors. HALO's investment software solution offering can be divided into two integrated elements - HALO Global and HALO Trading.
No incorporation details available.
DPS and Yield calculations use the Pay Date.
|Ms Louise McElvogue||Non-Executive Director||May 2021||
Ms Louise McElvogue
Ms McElvogue is an experienced executive and director with more than 20 years of experience with boards, corporates and start-ups. She has been involved in more than 30+ consumer technology projects across the UK, USA, Europe and Asia. She currently serves on several boards including Cluey Learning (ASX:CLU), a digital education platform and Healthdirect, the Federal & State Government consumer digital health platform. She also sits on the NSW Council of the Australian Institute of Company Directors and previously served on cybersecurity company WhiteHawk (ASX:WHK). Her executive and advisory experience includes more than 20 years in media, strategy and technology and leading over 30 digital projects in Australia, the UK and the US.
|Ms Philippa Mary Lewis||Non-Executive Director||May 2021||
Ms Philippa Mary Lewis
Ms Lewis is a professional company director with over 30 years of global, commercial experience. She has been a director and CEO in the digital, medtech, healthcare and life sciences sectors. As a strategic futurist she has founded multiple companies, led local and North American IPOs, reverse mergers, complex M&A transactions, raised and managed strategic capital for private and listed entities and has been engaged in multilateral joint ventures within North America, Europe and China. She currently serves on several boards as including Imunexus Therapeutics Ltd; a public unlisted company in the oncology therapeutics sector and Aquitas Pty Ltd, a privately owned residential aged care company. She has acted as a director of ASX and TSV listed MedTech company Simavita Ltd (ASX: SVA) between 2007 and 2016. She also chaired the board of Lifespot Health Ltd (ASX: LSH) (now, InhaleRx (ASX: IRX)) between September and October 2017, EZZ Life Science Holdings Limited (ASX:EZZ) between October 2020 and November 2021 and was chair and founder of Karista from 2016-2018, a private company servicing the aged, disability and community care sectors through a bespoke digital consumer choice platform. She has also served as a non-executive director of the Medical Technology Association of Australia. She has been nominated as Zurich Business Leader of the Year and Telstra Business Woman of the Year.
|Mr Ivan Oshry||Non-Executive Chairman,Non-Executive Director||May 2021||
Mr Ivan Oshry
Non-Executive Chairman,Non-Executive Director
Mr Oshry has more than 30 years of experience of legal practice in Australia and internationally, specialising in commercial and corporate law. He has advised on for both listed and unlisted entities and has been a guest speaker at various local, interstate and international seminars dealing with mergers and acquisitions and equity capital market topics. He has acted as co-legal counsel to the Offers. He sits on numerous company boards including EZZ Life Science Holdings Limited (ASX:EZZ), a distributor of branded skin care and consumer healthcare products; Jamieson Health Products Australia Pty Ltd, a subsidiary of Jamieson Wellness Inc, a Canada based listed company (TSE:JWEL), marketers and distributors of advanced natural-health products; PMFresh Pty Ltd and OpusXenta Pty Ltd, a technology company operating in the death care sector in Australia, New Zealand, the UK and the USA. He sits on the board of AAIG (and certain of its subsidiary companies).
|Mr Matthew Roberts||Managing Director||Oct 2020||
Mr Matthew Roberts
Mr Roberts has over 20 years of experience in financial services specialising in unique business structures, mergers, acquisitions and the development and growth of companies in Australia, Europe and the USA. In that time, he has worked on transactions across a variety of sectors, including financial services, healthcare, media, resources, information technology, digital currency and renewable energy. He is a Responsible Manager to the Australian Stock Exchange and is a former member of the Australian Digital Commerce Association's Advisory Board. MHe sits on the boards of AAIG (and certain of their subsidiary companies) and Domacom Limited (ASX: DCL).
|Mr George Paxton||Chief Executive Officer,Executive Director||Oct 2020||
Mr George Paxton
Chief Executive Officer,Executive Director
Mr Paxton is an experienced finance executive and has spent more than 15 years working in financial services with experience across in research, funds management and corporate finance across different geographies, including Europe, Asia and the USA. He has been involved in the creation of investment research products since 2006, on both the institutional and retail or high net worth side. Prior to moving to Australia in 2011, he was employed by Dealreporter, the Merger-Arbitrage division of Acuris, providing the client base of hedge funds and other institutional investors with actionable research and analysis. In Australia he has worked in equities research delivering research for a retail and high net worth client base, as a portfolio manager of investment products for retail investors, and at HALO since its inception. He sits on the boards of AAIG (and certain of their subsidiary companies) and Domacom Limited (ASX: DCL).
|Mr Nicolas Bryon||Executive Director||Oct 2020||
Mr Nicolas Bryon
Mr Bryon has been involved in creating management information systems since early in his career when he was first employed at QANTAS in 1995. He has experience in managing development teams to deliver product and infrastructure as well as providing the financial market and trading system knowledge to deliver world class applications that retail, high net worth investors and advisers alike require to manage their day-to-day investing activities. Mr Bryon has been involved in analysing companies and managing portfolios in financial markets for more than 20 years in various capacities. His early days in financial markets were in the capacity of a research analyst (1998-2001; resources and various other industries) and as a portfolio manager (2001-current) of various strategies including more traditional fundamental long only, long-short Australia & Asia and systematic arbitrage strategies.
|Ms Natalie Sylvia Climo||Company Secretary||N/A|
The current holdings of HAL directors.
|Director||Last Notice||Direct Shares||Indirect Shares||Options||Convertibles|
No Substantial Shareholders for HAL in our database.
12 month transaction history compiled from ASX announcements.
|Date||Name||Bought||Previous %||New %|
|26-04-22||Nicolas George Ashley Bryon||7,916,667||--||6.11|
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.